identified a tumor‐immune barrier in HCC, composed of SPP1+ macrophages and CAFs at the tumor edge, which are driven by hypoxia‐induced interactions that remodel the matrix and limit immune infiltration, thereby reducing anti‐PD‐1 efficacy.[262] Similarly, Qi et al. The gene discussed is PDCD1; the disease is neoplasm.